ArticleClinical immunology (Orlando, Fla.)2011

Is IL-4 a potential therapeutic target in systemic sclerosis-associated pulmonary fibrosis?

Petros P SfikakisPubMed ↗Publisher ↗

No numbers read from the abstract.